A well balanced, advanced article about prognostic indictor use and overuse in CLL with a discussion on MRD, minimal residual disease, and what it means...and a warning...
Handle with Care!
'MRD status should not be used to guide therapy outside of clinical studies because it is still the subject of ongoing research.'
Measurable residual disease (MRD) status predicts Progression Free Survival (PFS) for patients with Chronic Lymphocytic Leukemia (CLL)Use of MRD Status Following Obinutuzumab/Ibrutinib to Guide Subsequent Intensification of Therapy in CLLHelp the CLL Society find out what CLL patients & caregivers know and still "yearn to learn" about MRD testing + Limited Duration Therapies“MRD: What Should It Mean to Me?” Ever dreamed of coming to a point where your CLL treatment could be safely stopped? View CLL Webinar.
Prognostic markers and the future. Genetic testing.
